Search

Your search keyword '"Lopez-Reyes R."' showing total 76 results

Search Constraints

Start Over You searched for: Author "Lopez-Reyes R." Remove constraint Author: "Lopez-Reyes R."
76 results on '"Lopez-Reyes R."'

Search Results

1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

3. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

4. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

5. Timing and characteristics of venous thromboembolism after noncancer surgery

6. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

7. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

8. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

9. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

10. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

11. OC 01.2 Oxygen vs Ambient Air in Patients with Intermediate-Risk Acute Pulmonary Embolism: The Air Randomized Clinical Trial

12. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

13. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

15. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

16. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

17. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

19. DVT Management and Outcome Trends, 2001 to 2014

20. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

21. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

22. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

23. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

24. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

25. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

26. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

27. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

28. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

29. Predictors of active cancer thromboembolic outcomes

30. Pretriscuspid shunt and Eisenmenger syndrome: a deadly combination

31. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

32. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

33. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

34. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

35. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

36. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

37. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

38. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

39. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

40. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

41. Venous thromboembolism in young adults: Findings from the RIETE registry

42. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

43. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

44. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

45. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

47. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

48. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

49. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism

50. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism

Catalog

Books, media, physical & digital resources